The novel functions of cGMP-specific phosphodiesterase 5 and its inhibitors in carcinoma cells and pulmonary/cardiovascular vessels.
PDE5 is a opener enzyme intricate in the rule of cGMP-specific signaling pathways in normal physiological processes such as unbroken muscle contraction and relaxation. During this reason, bar of the enzyme can alter those pathophysiological conditions associated with a lowering cGMP plane in tissues. On prototype, selective PDE5 inhibitors, such as sildenafil (Viagra, Pfizer), tadalafil […]